Bulletin of Experimental Treatments for AIDS Table of Contents, Summer 2005

Now Live: Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

San Francisco AIDS Foundation

Bulletin of Experimental Treatments for AIDS
Table of Contents, Summer 2005

Features

Bulletin of Experimental Treatment for AIDS

Drug Interactions and Anti-HIV Therapy
By Liz Highleyman
A Guide to Clinical Trials: Part I -- Understanding Clinical Studies
By Liz Highleyman

Departments

News Briefs: Conference Coverage
By Liz Highleyman
Policy and Politics: Medicare Prescription Drug Coverage -- Preparing for January 1, 2006
By Jeffrey S. Crowley, M.P.H.
Drug Watch: Pipeline Progress -- Then and Now
By John Hawes
Women and HIV: Women's Research Roundup
By Kristen Jill Kresge
Open Clinical Trials for HIV/AIDS Treatments

News Flash

On July 1, as BETA went to press, Pfizer announced that it would stop clinical development of capravirine. Recent research showed that this experimental NNRTI did not offer a significant improvement over existing treatments, and that use of capravirine would likely be hampered by interactions with other anti-HIV therapies.

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Bulletin of Experimental Treatments for AIDS

Editorial Staff:

Editor: Nicholas Cheonis
Copy Editor: Liz Highleyman
Design and Production Manager: Paula Fener

Scientific Advisory Committee: George Beatty, M.D., M.P.H.; Lisa Capaldini, M.D.; Eric Goosby, M.D.; Cristina Gruta, Pharm.D.; Gregory Pauxtis, M.D.; Joanna Rinaldi; John Stansell, M.D.; Paul Wisotsky

Copyright
BETA is published biannually by the San Francisco AIDS Foundation. Funding provided by private and corporate donations. Copyright © 2005 by the San Francisco AIDS Foundation. All rights reserved. Articles may be reproduced for free distribution with acknowledgment of BETA and the author(s); for other uses, contact the editors. Brief passages may be quoted for review. Library of Congress ISSN 1058-708X.

Editorial office and mailing address:
P.O. Box 426182
San Francisco, CA 94142-6182
Telephone: (415) 487-8060
Fax: (415) 487-8069
E-mail: beta@sfaf.org
URL: www.sfaf.org/beta
©2005 San Francisco AIDS Foundation

This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS.

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.